Literature DB >> 288074

Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like material.

K H Gabbay, R M Bergenstal, J Wolff, M E Mako, A H Rubenstein.   

Abstract

Familial hyperproinsulinemia is an autosomal dominant defect that is associated with strikingly elevated levels of serum proinsulin-like material. Our studies show that trypsin converts familial hyperproinsulinemia proinsulin to insulin more slowly than it converts a 131I-labeled porcine proinsulin marker. Molar yields of insulin indicated that the material may be an intermediate proinsulin. Studies with two human C-peptide antisera that differ in their relative immunoreactivity with human C-peptide and proinsulin showed that the two antisera reacted equally with familial hyperproinsulinemia proinsulin, suggesting that it is a partially cleaved proinsulin intermediate. Sulfitolysis of highly purified material to break the inter- and intra-chain disulfide bridges and subsequent adsorption on a specific B-chain antibody covalently bound to Sepharose beads showed that the C-peptide was still connected to the B-chain. These data indicate that familial hyperproinsulinemia proinsulin is normally cleaved at the C-peptide-A-chain linkage site. A structural abnormality appears to underlie familial hyperproinsulinemia proinsulin, which impairs its cleavage at the B-chain-C-peptide linkage site.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 288074      PMCID: PMC383713          DOI: 10.1073/pnas.76.6.2881

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Amino acid sequences of proinsulins and intermediates.

Authors:  R E Chance
Journal:  Diabetes       Date:  1972       Impact factor: 9.461

3.  Isolation and characterization of proinsulin C-peptide from bovine pancreas.

Authors:  D F Steiner; S Cho; P E Oyer; S Terris; J D Peterson; A H Rubenstein
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

4.  Heterogeneity of circulating C-peptide.

Authors:  H Kuzuya; P M Blix; D L Horwitz; A H Rubenstein; D F Steiner; C Binder; O K Faber
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

5.  Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes.

Authors:  P Freychet; J Roth; D M Neville
Journal:  Biochem Biophys Res Commun       Date:  1971-04-16       Impact factor: 3.575

6.  Studies on the conversion of proinsulin to insulin. I. Conversion in vitro with trypsin and carboxypeptidase B.

Authors:  W Kemmler; J D Peterson; D F Steiner
Journal:  J Biol Chem       Date:  1971-11-25       Impact factor: 5.157

7.  Familial hyperproinsulinemia. An autosomal dominant defect.

Authors:  K H Gabbay; K DeLuca; J N Fisher; M E Mako; A H Rubenstein
Journal:  N Engl J Med       Date:  1976-04-22       Impact factor: 91.245

8.  Electrophoretic characterization of circulating human proinsulin and insulin.

Authors:  R A Gutman; N R Lazarus; L Recant
Journal:  Diabetologia       Date:  1972-04       Impact factor: 10.122

  8 in total
  15 in total

1.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

Authors:  G I Bell; J H Karam; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

2.  Proinsulin modified by analogues of arginine and lysine is degraded rapidly in pancreatic B-cells.

Authors:  P A Halban; M Amherdt; L Orci; A E Renold
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

3.  Assigning the polymorphic human insulin gene to the short arm of chromosome 11 by chromosome sorting.

Authors:  R V Lebo; Y W Kan; M C Cheung; A V Carrano; L C Yu; J C Chang; B Cordell; H M Goodman
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

4.  Localization of the human insulin gene to the distal end of the short arm of chromosome 11.

Authors:  M E Harper; A Ullrich; G F Saunders
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

5.  Posttranslational cleavage of proinsulin is blocked by a point mutation in familial hyperproinsulinemia.

Authors:  Y Shibasaki; T Kawakami; Y Kanazawa; Y Akanuma; F Takaku
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

Review 6.  Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene.

Authors:  Julie Støy; Donald F Steiner; Soo-Young Park; Honggang Ye; Louis H Philipson; Graeme I Bell
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

7.  A mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia.

Authors:  S J Chan; S Seino; P A Gruppuso; R Schwartz; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Scintigraphic distribution of 123 I labelled proinsulin, split conversion intermediates and insulin in rats.

Authors:  F Sodoyez-Goffaux; J C Sodoyez; M Koch; C J De Vos; B H Frank
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

9.  Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.

Authors:  D C Robbins; S E Shoelson; A H Rubenstein; H S Tager
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

10.  Pathogenetic mechanisms of hereditary diabetes mellitus.

Authors:  H W Rüdiger; M Dreyer
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.